Examiner Alexander Harrison
Grant ratio: 70.1% (63rd percentile in Art Unit 3636 among examiners with at least 20 applications). Average office actions per grant: 1.89. Most common rejection type: §103.
Appears inactive
Last office action in data: January 2017
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 26 | 60.5% | 1.69 |
| Group | 182 | 51.6% | 1.79 |
| Tech Center | 2,381 | 46.2% | 2.12 |
| USPTO | 16,475 | 52.7% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 113 | 46.3% |
| 2 OAs | 91 | 37.3% |
| 3 OAs | 24 | 9.8% |
| 4 OAs | 11 | 4.5% |
| 5+ OAs | 5 | 2.0% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2012 | 10 | 5 | 50.0% |
| 2013 | 67 | 48 | 71.6% |
| 2014 | 63 | 42 | 66.7% |
| 2015 | 59 | 39 | 66.1% |
| 2016 | 44 | 36 | 81.8% |
| 2017 | 1 | 1 | 100.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 244 | 0.0% | 14.8% | 71.3% | 13.9% |
| Action 2 | 131 | 0.0% | 17.6% | 77.9% | 3.8% |
| Action 3 | 40 | 0.0% | 12.5% | 85.0% | 0.0% |
| Action 4 | 16 | 0.0% | 18.8% | 81.3% | 0.0% |
| Action 5 | 5 | 0.0% | 20.0% | 60.0% | 20.0% |
| Action 6 | 2 | 0.0% | 0.0% | 50.0% | 50.0% |
Section 101 rejections
Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.
By year
0.0%
0.0%
2014: Alice
0.0%
0.0%
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Aug. 27, 2026.